Pages that link to "Q34597068"
Jump to navigation
Jump to search
The following pages link to Clinical relevance of E2F family members in ovarian cancer--an evaluation in a training set of 77 patients (Q34597068):
Displaying 50 items.
- Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers (Q24634248) (← links)
- Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer (Q33463860) (← links)
- E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer (Q33533979) (← links)
- Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets (Q33543156) (← links)
- Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway (Q33764131) (← links)
- Wiring miRNAs to pathways: a topological approach to integrate miRNA and mRNA expression profiles (Q33791204) (← links)
- Microarray-based oncogenic pathway profiling in advanced serous papillary ovarian carcinoma (Q33974923) (← links)
- Global gene expression profiling in three tumor cell lines subjected to experimental cycling and chronic hypoxia (Q34047326) (← links)
- Non-steroidal anti-inflammatory drugs decrease E2F1 expression and inhibit cell growth in ovarian cancer cells (Q34700681) (← links)
- Emerging roles of E2Fs in cancer: an exit from cell cycle control (Q35009182) (← links)
- Transcription factors and molecular epigenetic marks underlying EpCAM overexpression in ovarian cancer (Q35125662) (← links)
- An integrated network of microRNA and gene expression in ovarian cancer (Q35477129) (← links)
- Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer (Q35623109) (← links)
- Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer. (Q35924210) (← links)
- Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers. (Q36093220) (← links)
- The atypical E2F family member E2F7 couples the p53 and RB pathways during cellular senescence (Q36114088) (← links)
- E2F2 induction in related to cell proliferation and poor prognosis in non-small cell lung carcinoma (Q36261436) (← links)
- E2F8 as a Novel Therapeutic Target for Lung Cancer (Q36294944) (← links)
- E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter (Q36544743) (← links)
- E2F transcription factors and digestive system malignancies: how much do we know? (Q36897885) (← links)
- MiR-129 triggers autophagic flux by regulating a novel Notch-1/ E2F7/Beclin-1 axis to impair the viability of human malignant glioma cells (Q36962558) (← links)
- Aberrant Promoter Methylation at CpG Cytosines Induce the Upregulation of the E2F5 Gene in Breast Cancer (Q37056909) (← links)
- Survival-related profile, pathways, and transcription factors in ovarian cancer (Q37081275) (← links)
- The molecular mechanism of action of superactive human leptin antagonist (SHLA) and quadruple leptin mutein Lan-2 on human ovarian epithelial cell lines (Q37230628) (← links)
- Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer (Q37344480) (← links)
- Coordinate regulation of Fanconi anemia gene expression occurs through the Rb/E2F pathway (Q37374618) (← links)
- Atypical E2Fs: new players in the E2F transcription factor family (Q37388181) (← links)
- Evaluating L1CAM expression in human endometrial cancer using qRT-PCR. (Q37457845) (← links)
- Synergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer. (Q37644047) (← links)
- E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C (Q37716443) (← links)
- New players in ovarian cancer (Q37837735) (← links)
- Design of novel BH3 mimetics for the treatment of chronic lymphocytic leukemia (Q37997623) (← links)
- An emerging role for microRNAs in NF1 tumorigenesis (Q38060281) (← links)
- RB1 in cancer: different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis. (Q38077510) (← links)
- MicroRNA and transcription factor mediated regulatory network for ovarian cancer: regulatory network of ovarian cancer (Q38486395) (← links)
- E2F1: a promising regulator in ovarian carcinoma (Q38691452) (← links)
- Let-7b inhibits the malignant behavior of glioma cells and glioma stem-like cells via downregulation of E2F2. (Q38752222) (← links)
- MiR-218 Inhibited Growth and Metabolism of Human Glioblastoma Cells by Directly Targeting E2F2. (Q38870748) (← links)
- Analysis of genetic aberrations on chromosomal region 8q21-24 identifies E2F5 as an oncogene with copy number gain in prostate cancer. (Q39200185) (← links)
- A potential oncogenic role of the commonly observed E2F5 overexpression in hepatocellular carcinoma (Q39601497) (← links)
- E2F transcription factor 2 variants as predictive biomarkers for recurrence risk in patients with squamous cell carcinoma of the oropharynx (Q40444505) (← links)
- Expression and prognostic value of E2F activators in NSCLC and subtypes: a research based on bioinformatics analysis (Q40571013) (← links)
- An Atypical Oncogene Within the Atypical E2Fs. (Q42873660) (← links)
- Gene expression analysis of human endometrial endothelial cells exposed to op'-DDT. (Q46802060) (← links)
- Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-response (Q48197803) (← links)
- MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells (Q48595565) (← links)
- E2F3a gene expression has prognostic significance in childhood acute lymphoblastic leukemia (Q51092405) (← links)
- Evaluation of Vav3.1 as prognostic marker in endometrial cancer (Q57141071) (← links)
- Serve as Potential Prognostic Biomarkers and Targets for Human Ovarian Cancer (Q64061316) (← links)
- Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer (Q83943066) (← links)